Subsidies for the Basque Companies .

Filtra tu búsqueda

CIC biomaGUNE launches a company that will transform disease diagnosis by using nanosensors
18/02/2025 I+D+i

CIC biomaGUNE launches a company that will transform disease diagnosis by using nanosensors

Taldeki Biosolutions will be developing sensors for rapid, cost-effective, robust antibody detection, thus overcoming the stability and cost problems of current in vitro diagnostics

CIC nanoGUNE launches a new call: Industry Collaborative Research Positions
09/05/2024 R&D

CIC nanoGUNE launches a new call: Industry Collaborative Research Positions

Programa honen helburua da ikertzaile profesionalak tokiko erakundeetan sar daitezen erraztea

Basque Open Industry will show Europe its industrial and technological ecosystem at the European SME Week (SME Week) from 13 to 17 November.
27/09/2023 Digitalisation

Basque Open Industry will show Europe its industrial and technological ecosystem at the European SME Week (SME Week) from 13 to 17 November.

Talent, internationalisation, energy-environmental and technology-digital transitions. SME Week 2023. Exhibition and stands at the BEC: “Rebuild Ukraine”.

Aker Solutions selects TUBACEX as a delivery partner for umbilical tubes for key projects on the Norwegian Continental Shelf

Aker Solutions selects TUBACEX as a delivery partner for umbilical tubes for key projects on the Norwegian Continental Shelf

An order intake for a sum of more than €70 million is one of the most significant deals in the umbilicals market. Solidifying TUBACEX’s technological position as a supplier of advanced industrial solutions for energy and mobility sectors.

Energibasque. Executive Summary. Deployment of the Energy area RIS3 Basque Country.
02/02/2022 Innovation

Energibasque. Executive Summary. Deployment of the Energy area RIS3 Basque Country.

'Cleaner energies' is one of the areas of smart specialisation part of the Basque Country's RIS 3 Strategy and PCTI 2030.

‘Syngoi Technologies’:  Columbus VP creates a new company in Bizkaia for synthetic DNA production

‘Syngoi Technologies’: Columbus VP creates a new company in Bizkaia for synthetic DNA production

Columbus VP, a venture capital investment management company with a singular focus on business opportunities emerging in the biotechnology and life sciences sector.

SPRI Group will propose at the World Manufacturing Forum transformative actions to enhance the presence of women in the manufacturing industry
05/10/2021 Digitalisation

SPRI Group will propose at the World Manufacturing Forum transformative actions to enhance the presence of women in the manufacturing industry

Cristina Oyón has led the international group of experts that has drafted the report that will be disclosed on October 20th and 21st at the World Manufacturing Forum, which can be followed online for free upon registration

The Basque Government  participates  in the Research and production project for the vaccine against COVID 19, together with Harvard and the company VIRALGEN

The Basque Government participates in the Research and production project for the vaccine against COVID 19, together with Harvard and the company VIRALGEN

Tapia highlights that, once Harvard advances with the vaccine, the Basque Country is ready to take on this opportunity that represents  a unique health, social and business advance

VIVEbiotech SL new member of the Board of Directors of the Spanish Bioindustry Association (AseBio)

VIVEbiotech SL new member of the Board of Directors of the Spanish Bioindustry Association (AseBio)

AseBio brings together more than 730 companies that employ almost 100,000 people and invest more than € 400 million in R&D

VIVEbiotech makes a capital increase of 3.5 million euros to complete its expansion plan

VIVEbiotech makes a capital increase of 3.5 million euros to complete its expansion plan

in 2021 VIVEbiotech will be able to produce lentiviral vectors for advanced clinical trials

VIVEbiotech receives an issue notification of the patent grant for the LENTISOMA technology from the United States Patent and Trademark Office

VIVEbiotech receives an issue notification of the patent grant for the LENTISOMA technology from the United States Patent and Trademark Office

LENTISOMA is a new generation lentiviral vector whose most outstanding feature is related to the fact that it is not inserted into the genome of cells.

Columbus launches a €70 million fund for biomedicine

Columbus launches a €70 million fund for biomedicine

With the new investment fund, the managers plan to build two new plants in San Sebastian

Aludium invests 20 million euros in its Amorebieta plant

Aludium invests 20 million euros in its Amorebieta plant

El grupo ha anunciado la adquisición de un horno quemador con capacidad para fundir distintos tipos de chatarra

Binary code for new business models
19/03/2018 R&D

Binary code for new business models

COMA project, funded by The Basque Government's program HAZITEK, aims to develop a new supply of industrial services

Follow us

Specialized channels and daily news on our social profiles.